FDA Inspection 1133945 — Safe Harbor Clinical Research LLC
The FDA completed an inspection of Safe Harbor Clinical Research LLC on December 4, 2020 in East Providence, RI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 4, 2020
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- East Providence, RI (United States)
Additional Details
Clinical BA/BE